Alison Bauerlein Inogen Inc (INGN) insider trading activity

Alison Bauerlein is EVP, Finance, & CFO of Inogen Inc. Currently has a direct ownership of 33,902 shares of INGN, which is worth approximately $320,712. The most recent transaction as insider was on Jan 26, 2021, when has been sold 8,973 shares (Common Stock) at a price of $0.81 per share, resulting in proceeds of $7,268. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 33.9K

0% 3M change

0% 12M change

Total Value Held $320,712

Alison Bauerlein Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 26 2021	BUY Exercise of conversion of derivative security	$7,268 $0.81 p/Share	8,973 Added 44.29%	11,288 Common Stock
Jan 15 2021	SELL Open market or private sale	$806,447 $44.56 p/Share	18,098 Reduced 88.66%	2,315 Common Stock
Jan 15 2021	BUY Exercise of conversion of derivative security	$300,789 $16.62 p/Share	18,098 Added 46.99%	20,413 Common Stock
Dec 15 2020	SELL Open market or private sale	$351,561 $40.4 p/Share	8,702 Reduced 78.99%	2,315 Common Stock
Dec 15 2020	BUY Exercise of conversion of derivative security	$144,627 $16.62 p/Share	8,702 Added 44.13%	11,017 Common Stock
Dec 01 2020	SELL Payment of exercise price or tax liability	$12,172 $35.28 p/Share	345 Reduced 1.05%	32,470 Common Stock
Dec 01 2020	BUY Grant, award, or other acquisition	$8,926 $35.28 p/Share	253 Added 0.77%	32,815 Common Stock

Also insider at

PEAR

Pear Therapeutics, Inc. Healthcare

Director

GLS

GELESIS HOLDINGS, INC. Healthcare

Director

SGHT

Sight Sciences, Inc. Healthcare

Chief Financial Officer